Pemvidutide improves fibrosis markers, liver fat, lipids, weight, and blood pressure in patients with MASH at 1 year, phase ...
Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that new 48-week data from the IMPACT Phase 2b ...
Blood pressure medications work in different ways to bring blood pressure to within an optimal range. Read on for more.
From narrow volume windows to SGLT2 inhibitors and emerging devices, Drs Kevin Alexander and Sarah Cuddy discuss heart ...
A large phase 3 clinical trial has revealed promising results for a once-nightly pill designed to treat obstructive sleep ...
In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Mary-Elizabeth Patti, MD, and ...
Courtney Southwick is a writer focusing on health, nutrition, and disease. She has been blogging for the past two years at CourtneySouthwick.com. She writes blogs and articles for online publications ...
Over 40% of people taking Xenical achieved a 5% decrease in their starting body weight. Saxenda users achieved a 5% decrease in their body weight in more than 63% of cases. Eating a balanced diet and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results